Bozelko column: Clinical trials in prisons are a good idea,

Drug maker Alkermes ran a randomized double-blind trial of its injectable Vivitrol in correctional facilities between 2011 and 2014. Eighty-five percent of …, Drug maker Alkermes ran a randomized double-blind trial of its injectable Vivitrol in correctional facilities between 2011 and 2014. Eighty-five percent of …, Read More